{
    "Trade/Device Name(s)": [
        "AvieTM A1C System",
        "AvieTM A1C Test System",
        "AvieTM A1C System Reader",
        "AvieTM A1C System Test Cartridge",
        "AvieTM A1C System Diluent"
    ],
    "Submitter Information": "MEC Dynamics Corporation",
    "510(k) Number": "K093548",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091400"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "July 1, 2011",
    "Summary Letter Received Date": "July 6, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (A1C)",
        "Total hemoglobin"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "AvieTM A1C System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "General chemistry",
        "Optical detection"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemistry assay"
    ],
    "Submission Type(s)": [
        "System",
        "Reader",
        "Test Cartridge",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for AvieTM A1C System, a point-of-care immunoassay system measuring glycated hemoglobin for diabetes monitoring",
    "Indications for Use Summary": "Quantitatively measures %A1C (glycated hemoglobin) in capillary and venous whole blood for physician-directed prescription home use and professional use to monitor glycemic control in patients with diabetes mellitus; not for use in patients with hemoglobinopathies of Hemoglobin C and Hemoglobin D",
    "fda_folder": "Hematology"
}